Diffuse large B-cell lymphoma (DLBCL): Researcher interview

from The Blood Cancer Experience Hosted by LLSC

Researchers are focused on maintaining an excellent cure rate in diffuse large B-cell lymphoma (DLBCL) and minimizing some of the treatment individuals receive – reduce the number of cycles of chemotherapy or avoid radiation, and looking at new drugs to improve the cure rate for others with DLBCL. Join us as we chat with Dr. John Kuruvilla, working as a hematologist-oncologist for 20 years (currently at the Princess Margaret Cancer Centre in Toronto) including as a researcher in DLBCL, which is the largest form on non-Hodgkin lymphoma. Learn more about DLBCL at: https://www.bloodcancers.ca/diffuse-large-b-cell-lymphoma-dlbcl

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

Diffuse large B-cell lymphoma (DLBCL): Researcher interview

0:00 17:55

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Frequently asked questions

How long is this episode of The Blood Cancer Experience?

This episode is 17 minutes long.

When was this The Blood Cancer Experience episode published?

This episode was published on February 8, 2024.

Can I download this The Blood Cancer Experience episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.